Peru
4 Vaccines Approved for Use in Peru
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: gob.pe
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: digemid.minsa.gob.pe
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
29 trials in 12 countries
Approval Source: reuters.com
4 in Clinical Trials in Peru
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
29 trials in 12 countries
Inactivated
Sinopharm (Wuhan)
Inactivated (Vero Cells)
Approved in 2 countries
9 trials in 7 countries
1 Vaccines with Trials in Peru are No Longer Progressing
RNA
Curevac
CVnCoV
9 trials in 12 countries